Matthias Pinter
Impact in
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Liver physiology and pathology
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 94
- Hepatocellular Carcinoma Treatment and Prognosis 56
- Liver Disease and Transplantation 37
- Hepatitis C virus research 10
- Epidemiology 29
- Liver Disease Diagnosis and Treatment 27
- Co-authors
- Markus Peck‐Radosavljevic (46 shared papers)Michael Trauner (83 shared papers)Wolfgang Sieghart (35 shared papers)Bernhard Scheiner (72 shared papers)Thomas Reiberger (66 shared papers)Rakesh K. Jain (4 shared papers)Christian Müller (13 shared papers)Florian Hucke (20 shared papers)
- Journals
- Journal of Hepatology (23 papers)Alimentary Pharmacology & Therapeutics (10 papers)Journal of Clinical Oncology (9 papers)United European Gastroenterology Journal (7 papers)Cancers (6 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Matthias Pinter
143 papers receiving 4.8k citations
Matthias Pinter's Hit Papers
Peers
Comparison fields: 5 of 115
- Hepatology 2.6k
- Epidemiology 1.2k
- Oncology 811
- Cancer Research 415
- Pathology and Forensic Medicine 398
Countries citing papers authored by Matthias Pinter
This map shows the geographic impact of Matthias Pinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Pinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Pinter more than expected).
Fields of papers citing papers by Matthias Pinter
This network shows the impact of papers produced by Matthias Pinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Pinter. The network helps show where Matthias Pinter may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Pinter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma Hit paper breakdown → | 2020 | 251 |
| 2 | 2013 | 250 | |
| 3 | 2017 | 241 | |
| 4 | 2012 | 230 | |
| 5 | 2016 | 204 | |
| 6 | 2012 | 174 | |
| 7 | 2020 | 169 | |
| 8 | 2009 | 140 | |
| 9 | 2018 | 132 | |
| 10 | 2020 | 131 | |
| 11 | 2018 | 123 | |
| 12 | 2014 | 117 | |
| 13 | 2017 | 112 | |
| 14 | 2019 | 101 | |
| 15 | 2012 | 100 | |
| 16 | 2012 | 95 | |
| 17 | 2011 | 84 | |
| 18 | Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW. Hit paper breakdown → | 2024 | 83 |
| 19 | 2013 | 82 | |
| 20 | 2023 | 80 |
About Matthias Pinter
Matthias Pinter is a scholar working on Hepatology, Epidemiology, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 162 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (56 papers), Liver Disease and Transplantation (37 papers), Liver Disease Diagnosis and Treatment (27 papers), Cancer Immunotherapy and Biomarkers (11 papers), Hepatitis C virus research (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Hepatology (2.6k citations), Epidemiology (1.2k citations), Oncology (811 citations), Cancer Research (415 citations) and Pathology and Forensic Medicine (398 citations). Matthias Pinter has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Markus Peck‐Radosavljevic, Michael Trauner, Wolfgang Sieghart, Bernhard Scheiner, Thomas Reiberger, Rakesh K. Jain, Christian Müller, Florian Hucke, Dan G. Duda and Ivo Graziadei. Their work appears in journals such as Journal of Hepatology, Alimentary Pharmacology & Therapeutics, Journal of Clinical Oncology, United European Gastroenterology Journal and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.